SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.81-4.3%Dec 2 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16334)10/9/2003 11:02:48 AM
From: aknahow   of 17367
 
perhaps, he knows Raptiva does not work and sold Xoma short @ $12.50?<g>

Actually a very good ad (non ad) as ads prior to approval would be illegal. Really great concept. After approval Raptiva trial subjects can be quoted as to why they are smiling.

BW says t.v. won't be used, and that makes sense but a lot can be done with smiling faces in literature provided by derms to acquaint patients with Raptiva.

Nice find. Also proves a company can say something when it wants too. Even the lawyers had to sign off, because when you think about it no FDA rule prevents you from showing the face of a clinical trial subject smiling. And 75% of the thousands that were in the trial probably have smiles.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext